August 18, 2025Deleted Journal

Nuklearmedizinische Optionen bei fortgeschrittenem Prostatakarzinom in der Praxis

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Observational analysis highlights PSMA PET/CT's accuracy for detecting metastases in prostate cancer, suggesting potential for radioligand therapy.

PSMA radioligand therapy shows promise in treating advanced prostate cancer, particularly in later stages.
Current comparison indicates PSMA-PET/CT is more accurate than CT and bone scintigraphy for metastasis detection.
Theranostic approach allows tailored treatments based on PSMA expression in tumor lesions, with further studies needed.
Combination therapies with PSMA radioligand therapy are under investigation, offering hope for earlier intervention.

Kunte et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Observational analysis highlights PSMA PET/CT's accuracy for detecting metastases in prostate cancer, suggesting potential for radioligand therapy.